SARM1 and amyotrophic lateral sclerosis: To determine whether Sarm1 deletion could attenuate TDP-43-mediated neurotoxicity we designed a crossing scheme to knock out Sarm1 from a transgenic mouse model of ALS that overexpresses human mutant TDP-43Q331K under the mouse prion promoter [4].